The International Society for Cell and Gene Therapy is pushing back against a Utah law that allows healthcare providers to treat patients with placental stem cell therapies that haven’t been approved by the FDA. The group is concerned that the law will open up a way to work around the…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
